ansipastobart (BR101)
/ Zhejiang Hisun Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2023
A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1